Invivyd Correlations
| IVVD Stock | USD 1.61 0.06 3.87% |
The current 90-days correlation between Invivyd and OmniAb Inc is -0.07 (i.e., Good diversification). The correlation of Invivyd is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Invivyd Correlation With Market
Excellent diversification
The correlation between Invivyd and DJI is -0.55 (i.e., Excellent diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Invivyd and DJI in the same portfolio, assuming nothing else is changed.
Moving together with Invivyd Stock
| 0.77 | OSE | OSE Pharma SA | PairCorr |
| 0.81 | RAC | Race Oncology | PairCorr |
| 0.69 | VCYT | Veracyte Earnings Call This Week | PairCorr |
| 0.71 | 9OF | BIORESTORATTHERAPDL | PairCorr |
| 0.89 | BIM | Biomerieux SA Earnings Call This Week | PairCorr |
Moving against Invivyd Stock
| 0.79 | CMB | Cambium Bio Earnings Call This Week | PairCorr |
| 0.77 | 6C1 | CytomX Therapeutics | PairCorr |
| 0.75 | PYC | Physiomics Plc | PairCorr |
| 0.74 | DNTH | Dianthus Therapeutics | PairCorr |
| 0.71 | DNLI | Denali Therapeutics Earnings Call This Week | PairCorr |
| 0.63 | DRTS | Alpha Tau Medical | PairCorr |
| 0.58 | SABSW | SAB Biotherapeutics | PairCorr |
| 0.57 | DSGN | Design Therapeutics | PairCorr |
| 0.54 | VALN | Valneva SE ADR | PairCorr |
| 0.5 | EQ | Equillium | PairCorr |
| 0.49 | GXEA | Galapagos NV | PairCorr |
| 0.48 | JUMP | Leveljump Healthcare Corp Earnings Call This Week | PairCorr |
| 0.48 | 2CG | NANOSPHERE HEASCIENCES | PairCorr |
| 0.46 | 8VP1 | AVRICORE HEALTH INC | PairCorr |
| 0.44 | AVH | Avita Medical | PairCorr |
| 0.39 | SAB | Sonic Healthcare | PairCorr |
| 0.84 | S09 | Sutro Biopharma Split | PairCorr |
| 0.68 | 0P6S | Bayer AG NA | PairCorr |
| 0.66 | DVAX | Dynavax Technologies | PairCorr |
| 0.57 | TF2 | Takara Bio | PairCorr |
| 0.56 | SRZNW | Surrozen Warrant | PairCorr |
| 0.56 | VRTX | Vertex Pharmaceuticals | PairCorr |
| 0.53 | ALA | Arovella Therapeutics Earnings Call This Week | PairCorr |
| 0.47 | NANO | Nanobiotix SA | PairCorr |
Related Correlations Analysis
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Invivyd Stock performing well and Invivyd Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Invivyd's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| OABI | 2.31 | 0.07 | 0.04 | 0.12 | 2.45 | 5.99 | 15.55 | |||
| GNFT | 3.17 | 0.66 | 0.11 | (2.17) | 3.86 | 7.34 | 25.18 | |||
| CCCC | 3.54 | (0.20) | 0.00 | (0.08) | 0.00 | 8.45 | 25.16 | |||
| TARA | 3.66 | 0.49 | 0.08 | (1.41) | 4.74 | 11.13 | 39.96 | |||
| IMDX | 3.71 | (0.46) | 0.00 | (0.17) | 0.00 | 7.58 | 32.12 | |||
| SGMO | 4.59 | (0.13) | 0.00 | 0.03 | 6.04 | 9.52 | 73.25 | |||
| CDXS | 3.39 | (0.58) | 0.00 | (0.21) | 0.00 | 5.66 | 21.68 | |||
| NTHI | 5.13 | 0.12 | 0.05 | 0.10 | 5.98 | 9.99 | 41.97 | |||
| OBIO | 3.60 | (0.06) | 0.00 | 0.04 | 4.02 | 10.17 | 22.05 | |||
| SLS | 5.45 | 1.84 | 0.27 | 6.28 | 5.26 | 14.94 | 34.72 |
Invivyd Corporate Management
| Laura Walker | CoFounder Officer | Profile | |
| Elham PharmD | Chief Officer | Profile | |
| Peter MD | Chief Officer | Profile | |
| Robert Allen | Chief Officer | Profile | |
| Jill JD | Chief Secretary | Profile | |
| Mark Wingertzahn | Senior Affairs | Profile | |
| Timothy Lee | Chief Officer | Profile |